CIK 0001398733
- Non-accelerated filer
- Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208623253
- Phone
- +1 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- Open-market buys, last 90 days
- $99,331
- in 1 filing
- Open-market sales, last 90 days
- $297,289
- in 4 filings, $297K under 10b5-1 plans
Net −$197,958. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-02 | BRATTON DOUGLAS K 10% owner | Gift | −40,000 | 199,841 | ||
| 2021-03-12 | BRATTON DOUGLAS K 10% owner | Other disposition | −524,675 | 1,688,639 | ||
| 2021-03-12 | BRATTON DOUGLAS K 10% owner | Other disposition | −564,160 | 3,468,747 | ||
| 2021-03-12 | BRATTON DOUGLAS K 10% owner | Other disposition | −97,598 | 2,657,943 | ||
| 2021-03-12 | BRATTON DOUGLAS K 10% owner | Other disposition | −40,404 | 47,051 | ||
| 2021-03-12 | BRATTON DOUGLAS K 10% owner | Other disposition | −2,249,077 | 0 | ||
| 2021-03-12 | BRATTON DOUGLAS K 10% owner | Other acquisition | +1,783,578 | 1,948,578 | ||
| 2021-03-09 | BRATTON DOUGLAS K 10% owner | Gift | −62,500 | 12,585 | ||
| 2020-06-16 | BRATTON DOUGLAS K Director | Grant or award · Stock Option (Right to Purchase) | +14,000 | 14,000 | ||
| 2019-06-13 | BRATTON DOUGLAS K Director | Grant or award · Stock Option (Right to Purchase) | +13,350 | 13,350 | ||
| 2018-07-24 | BRATTON DOUGLAS K Director | Grant or award · Stock Option (Right to Purchase) | +26,700 | 26,700 | ||
| 2018-07-24 | BRATTON DOUGLAS K Director | Purchase | +165,000 | $15.00 | $2.5M | 165,000 |
Page 1 of 1 · 12 trades